TURN CANCER AGAINST ITSELF
Live / Applied — First extension granted (statement of use) (as of 02 Jun 2025)
What this means for you
Not registered yet, but its 14 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98405995
- Mark type
- Stylized text
- Filed
- 14 Feb 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Ted D. Karr
Goods and services
- Class 005 — Pharmaceuticals: Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
- Class 044 — Medical, beauty and agricultural services: Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer
Owner
- Earli Inc., Redwood City, CA, US
- Earli Inc., Redwood City, CA, US
Prosecution history
- 13 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jun 2025 — SOU EXTENSION 1 GRANTED
- 02 Jun 2025 — SOU EXTENSION 1 FILED
- 02 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION
- 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Sept 2024 — ASSIGNED TO EXAMINER
- 17 Jun 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Feb 2024 — NEW APPLICATION ENTERED